AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
16 hedge funds and large institutions have $18M invested in Ambrx Biopharma Inc in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$57.1K | |
| 2 | +$46K | |
| 3 | +$21K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13K |
| 5 |
Millennium Management
New York
|
+$11.8K |
Top Sellers
| 1 | -$325K | |
| 2 | -$291K | |
| 3 | -$165K | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$162K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$3.03K |